Showing results (11-20 of 542) with videos related to
Sort By:
Pageof 55
Pharmacological Research|November 20, 2001
PPARS, metabolic disease and atherosclerosisJ C Fruchart, B Staels, P DuriezJournal De La Societe De Biologie|June 14, 2000
[Molecular mechanism of action of the fibrates]J C Fruchart, P Duriez, B StaelsArchives Des Maladies Du Coeur Et Des Vaisseaux|July 31, 2004
PPAR alpha, fibrates, lipid metabolism and inflammationC Duval, J C Fruchart, B StaelsInflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 23, 2000
Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammationG Chinetti, J C Fruchart, B StaelsDiabetes, Obesity & Metabolism|September 3, 2015
Skeletal muscle functions around the clockA Mayeuf-Louchart, B Staels, H DuezThe Journal of Clinical Investigation|June 8, 2001
Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-IG Martin, H Duez, C Blanquart, et al.Biochemical Pharmacology|September 29, 2000
Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosisB P Neve, J C Fruchart, B StaelsBiomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 22, 2005
Therapeutical effects of PPAR agonists assessed by biomarker modulationG Chinetti-Gbaguidi, J-C Fruchart, B StaelsAtherosclerosis|July 1, 1996
Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPARJ Auwerx, K Schoonjans, J C Fruchart, et al.Biochimie|February 1, 1997
The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs)B Staels, K Schoonjans, J C Fruchart, et al.Pageof 55